BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luong TV, Tran H, Hoang Thi BN, Vu HM, Le TT, Le TT, Tran Thi HT, Nguyen HM, Doan TC, Ho BA, Hoang TA, Dang HNN. Integrating liver and heart health: Cardiovascular risk reduction in patients with metabolic-associated steatotic liver disease. World J Cardiol 2025; 17(7): 107751 [PMID: 40741021 DOI: 10.4330/wjc.v17.i7.107751]
URL: https://www.wjgnet.com/1948-5182/full/v17/i7/107751.htm
Number Citing Articles
1
Jorge Gutiérrez-Cuevas, Ana Sandoval-Rodriguez, Jesús Garcia-Bañuelos, Marcelo Heron Petri, Juan Armendariz-Borunda. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular diseaseWorld Journal of Gastroenterology 2026; 32(35): 119898 doi: 10.3748/wjg.119898
2
Xiangsui Hu, Hanwei Chen, Ziying Wang, Yun Deng, Long Huang, Chunquan Zhang, Liangyun Guo, Shengbo Liu, Lingmin Liao. TyG index and MAFLD severity are associated with subclinical LV dysfunction in T2DM patients: a cross−sectional studyFrontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1749989